跳至主要内容
临床试验/IRCT20181109041596N1
IRCT20181109041596N1招募中3 期

Evaluation of effect of fluoxetine on the clinical prognosis in patients with anterior ischemic optic neuropathy (AION) according to evaluations of visual acuity and VEP tests as main outcomes, in comparison between drug and placebo groups.

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Iranian patients
  • Age over 18 years old
  • Patients with diagnosis of AION; non-arteritic type

排除标准

  • Pregnancy before or during study
  • Past medical history of cataract, glaucoma ( open or close angle ) congenital eye disease such as cloboma and involvement with disease effecting the central visual field of patient
  • Patients with past medication history of using fluoxetine or other psychological medications including antidepressants
  • Patients suffering from psychological disease
  • Patients who use medications including :arthemeter? astemizol, cisapride, eliglustat, goserelin, isocarboxazide, artemether, leuprolide, linezolid, lumefantrine, methylene blue, phenelzine, pimozide, procarbazine, selegiline, thioridazine, tranylcypromine
  • Patients diagnosed with immunologic and collagen vascular disease
  • Patients with symptoms of or diagnosed with giant cell arteritis and positive CRP more than 3+ or ESR more than 40
  • Trauma or surgery history of eyes
  • Duration between involvement and interview more than 3 weeks
  • Patients without compliance of using fluoxetine or disagrement of patient to continue accompanying the study
  • Involvement by glaucoma
  • Involvement by cataract
  • Change in depression questionnaire score lower than 1 score in comparison to first and forth visit ( means the poor compliance of patient that has not used fluoxetine
  • Death of patient

研究者

相似试验

Evaluation of effect of fluoxetine on the clinical... | 临床试验